Predictive Value of 18F-FAZA in Rectum Cancer
NCT01257035 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2013-06-17
Summary
The primary purpose of the study is to investigate 18F-FAZA-PETs role as predictor of response to neoadjuvant chemoradiation of locally advanced rectum cancer.
Conditions
- Locally Advanced Rectum Cancer
Interventions
- OTHER
-
18F-FAZA-PET/CT
Contrast fluid injected prior to scan
Sponsors & Collaborators
-
Aarhus University Hospital
collaborator OTHER -
Vejle Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2012-02-29
- Completion
- 2012-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA
NCT00756691 ·Status: WITHDRAWN
-
18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer
NCT01636674 ·Status: UNKNOWN ·Phase: NA
-
FAZA PET as Biomarker for Hypoxia in Rectal Cancer
NCT02624115 ·Status: COMPLETED
-
Rectal Cancer Response Hybrid Imaging Assessement
NCT04036643 ·Status: UNKNOWN ·Phase: NA
-
Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI
NCT01525056 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
NCT00765986 ·Status: UNKNOWN
-
18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma
NCT05531045 ·Status: NOT_YET_RECRUITING
-
11C- and 18F-Choline PET/MR Imaging for Prostate Cancer
NCT02397408 ·Status: COMPLETED ·Phase: PHASE2
-
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
NCT00499395 ·Status: COMPLETED ·Phase: NA
-
The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma
NCT06355427 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)
NCT04524195 ·Status: TERMINATED ·Phase: PHASE1
-
[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib
NCT02175095 ·Status: COMPLETED ·Phase: NA
-
FDG - PET / MRI in Patients With Rectal Cancer
NCT03846882 ·Status: UNKNOWN
-
FAZA PET/MRI Sarcoma
NCT03418818 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma
NCT05209750 ·Status: UNKNOWN ·Phase: NA
-
18F-DCFPyL PET-CT Scan and Prostate Cancer
NCT03852654 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
FAZA PET/MRI Pancreas
NCT04395469 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
NCT04678440 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
NCT06644716 ·Status: RECRUITING ·Phase: NA
-
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
NCT04158245 ·Status: COMPLETED ·Phase: PHASE2
-
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
NCT02809690 ·Status: TERMINATED ·Phase: PHASE1
-
18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment
NCT02680041 ·Status: COMPLETED ·Phase: PHASE3
-
Imaging of Solid Tumors Using 18F-TRX
NCT06942104 ·Status: RECRUITING ·Phase: PHASE1
-
FAZA PETMRI Gastro-Oesophageal Study
NCT04560036 ·Status: RECRUITING ·Phase: NA